Publications
At MIT: Coming Soon!
Prior To MIT:
9.
Mitoribosome sensitivity to HSP70 inhibition uncovers metabolic liabilities of castration-resistant prostate cancer
Echtenkamp FJ, Ishida R, Rivera-Marquez GM, Maisia M, Johnson OT, Shrimp JH, Sinha A, Ralph SJ, Nisbet I, Cherukuri MK, Gestwicki JE, Neckers LM.
8.
Allosteric inhibition of Hsp70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived models
Xu P, Yang, JC, Ning S, Chen B, Nip C, Wei Q, Liu L, Johnson OT, Gao AC, Gestwicki JE, Evans CP, Liu C.
*these authors contributed equally